Previous 10 | Next 10 |
2024-01-04 13:51:02 ET More on BioNTech, Moderna, etc. Pfizer: If You Missed The Pandemic Entry, Here's Another Chance BioNTech's Strategic Shift: Diversifying Into Cancer Therapeutics The Pfizer Advantage: High Dividend Yield, JN.1 Variant, And Therapeutic Innovatio...
Novavax to Participate in the 42nd Annual J.P. Morgan Healthcare Conference PR Newswire GAITHERSBURG, Md. , Jan. 3, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today...
2024-01-02 12:32:09 ET More on COVID vaccine makers BioNTech's Strategic Shift: Diversifying Into Cancer Therapeutics Novavax: Do Not Expect A Turnaround In 2024 BioNTech's COVID-19 Success Paves The Way For A Strong Drug Pipeline Moderna upgraded at Oppenhei...
2023-12-28 15:21:17 ET More on Novavax Novavax: Do Not Expect A Turnaround In 2024 Novavax, Inc. (NVAX) Presents at Jefferies London Healthcare Conference (Transcript) Novavax: Less Is Less - Shrinking COVID Market Takes Its Toll (Rating Downgrade) JN.1 Omicr...
2023-12-27 02:55:50 ET Summary Novavax faces major challenges in 2024, including a significant Gavi dispute and going concern issues. Recent financial results show declining revenues and cash reserves, with a high operational cash burn rate. Market sentiment is cautious, with ...
2023-12-26 07:02:44 ET More on BioNTech, Moderna, etc. BioNTech's COVID-19 Success Paves The Way For A Strong Drug Pipeline Pfizer: Buy The Panic Pfizer Is Not Cheap, And The 5.7% Yield Is Not As Safe As You Might Think Citi puts Pfizer on catalyst watch afte...
2023-12-25 10:03:02 ET Summary I discuss my investment and trading strategies before and after March 2022. I highlight the importance of trade income, capital gains, dividend collection, and tax harvesting in my investment approach. I want to see the Bull Plateau (or Bear-Mark...
2023-12-20 13:46:26 ET Summary Pfizer's stock reached an all-time high in 2021 due to high demand for its COVID-19 vaccine but has since declined by 45% year-to-date. The company has revised its financial guidance for FY24, expecting significantly lower sales and profits. Decl...
Novavax's Updated COVID-19 Vaccine Receives Emergency Use Authorization in Taiwan PR Newswire Novavax's updated vaccine will be available at vaccination centers across Taiwan GAITHERSBURG, Md. , Dec. 18, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq:...
2023-12-18 05:43:43 ET Summary The best performance of the bull plateau is to advance steadily, not to move monotonously, and support for loyal cash cows. The article discusses winners in various categories such as Mega-Cap Group, Large-Cap Group, Small-Cap Group, Top Gains, All T...
News, Short Squeeze, Breakout and More Instantly...
Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine Canada NewsWire Novavax's COVID-19 vaccine would be the only protein-based option available in Canada , if authorized Novavax's filing is aligned with NACI, ...